Two options that often come up are Ozempic (semaglutide) and compounded semaglutide
4 Ozempic (Semaglutide 0.25 mg, 0.5 mg, 1 mg, & 2 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity and overweight
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA 318(15): 146070
Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A
If you dont meet these eligibility criteria, Aetna will sometimes cover other weight loss medications, such as Wegovy, as long as you meet specific criteria and receive prior authorization for those medications
Retatrutide Phase 3 TRIUMPH-4 (NCT05931367, 445 participants, 68 weeks) reported 28.7% body weight loss at 12 mg, 26.4% at 9 mg, vs 2.1% placebo